Regenerative Medicine Market to be Valued at USD 6.49 Billion by 2027 | The Escalating Burden of Chronic Diseases and Genetic Aberrations will be the Major Factor Driving the Industry Growth, says Emergen Research

Major industry players are F. Hoffmann-La Roche Ltd, Astellas Pharma Inc., Bayer BV, Corline Biomedical AB, Integra LifeSciences Corporation, Merck & Co., Inc., Pfizer Inc., Abbott, AstraZeneca, and COOK BIOTECH, INC., among others.

Surrey, CANADA

Vancouver, British Columbia, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The Global Regenerative Medicine Market is predicted to attain a market valuation of USD 6.49 billion by 2027, growing at a CAGR of 9.3% throughout the estimated period, according to a recent analysis by Emergen Research. Targeted therapy of specific disease indication and chronic illnesses are anticipated to alter the dynamics of the healthcare field. The escalating prevalence of chronic health conditions and increasing patient pool of geriatric populace coupled with neurodegenerative disorders, cancers, orthopedic, and other age-related conditions are further bolstering the industry’s expansion.

The numerous applications and subsequent advancements in tissue engineering, gene therapy, nanotechnology, and stem cells research are foreseen to boost the scope of regenerative medicine. 3D printing is playing a pivotal role in stem cells research as it allows for the easy restoration of structural and functional properties.

North America is predicted to occupy a significant share of the market in the projected timeframe and the growth can be attributed to the increasing number of academic institutions and universities extensively exploring regenerative medicine approaches based on stem cells.

Claim Your FREE Sample Copy with Table of content@

Key Highlights from the Report:

  • The therapeutics segment is anticipated to command the market growth owing to the rising application of primary and progenitor stem-cell-based therapeutic approaches.
  • Primary cell-based therapies are extensively useful in healthcare disciplines such as dermatology, musculoskeletal applications, and dentistry. The dermatology segment is predicted to garner significant market share owing to the mounting prevalence of chronic wounds associated with diabetes and HIV, thereby furthering the research scope in the field.
  • The growing financial support for research activities and the escalating number of stem cell labs are further contributing to the expansion of progenitor cell and stem cell-based therapies.
  • North America accounted for a substantial share of the industry in 2019 and is estimated to continue holding its leading position due to an increased number of ongoing clinical trials, the emergence of innovative technology, and the extensive research studies conducted by research institutions to develop novel therapies.
  • The Asia Pacific is forecast to be expanding rapidly in the given timeframe owing to the rapid development of advanced healthcare infrastructure and facilities and a significant expansion of stem cell research.
  • Major industry players are F. Hoffmann-La Roche Ltd, Astellas Pharma Inc., Bayer BV, Corline Biomedical AB, Integra LifeSciences Corporation, Merck & Co., Inc., Pfizer Inc., Abbott, AstraZeneca, and COOK BIOTECH, INC., among others.
  • In 2018, Convelo Therapeutics developed and launched regenerative medicines for the treatment of a broad spectrum of neurological conditions, including multiple sclerosis.
  • Hitachi Chemical and Daiichi Sankyo and the SanBio Group partnered in 2018 to enhance the clinical manufacturing of regenerative medicine products developed by various companies in the U.S. and Japanese market respectively.

Claim Your FREE Sample Copy with Table of content@

For the purpose of this report, Emergen Research has segregated the Global Regenerative Medicine Market on the basis of product, therapeutic category, application, and region:

Product Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • Therapeutics
  • Tools
  • Banks
  • Services

Therapeutic Category Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • Dermatology
  • Musculoskeletal
  • Immunology & Inflammation
  • Oncology
  • Cardiovascular
  • Ophthalmology
  • Others

Application Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:

Regional Outlook (Volume, Million Tons; Revenue, USD Billion; 2017-2027)

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Rest of LATAM
  • Middle East & Africa
  • Saudi Arabia
  • U.A.E.
  • Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release: